GLP-Compliant Services (Regulatory)
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
Good Laboratory Practice (GLP) services from GENEWIZ are designed to be compliant with US FDA (21 CFR Part 58) and US EPA (40 CFR Part 160) regulations to support pre-marketing authorizations.
GENEWIZ provides CLIA Sanger sequencing as the clinical "gold standard" from our state-of-the-art CLIA-certified and CAP-accredited laboratory.
CLIA variant confirmation via PCR + Sanger sequencing is used to detect or confirm mutations within genomic DNA.
To support pre-clinical and clinical regulatory submissions, GENEWIZ has established Good Laboratory Practices (GLP) and Clinical Laboratory Improvement Amendments (CLIA)-compliant workflows.
GENEWIZ from Azenta Life Sciences combined regulatory services support your preclinical and clinical regulatory submissions. Our US laboratories are GLP and CLIA compliant and CAP accredited.
GENEWIZ AAV Plasmid Preparation service delivers superior quality for midi to giga-scale AAV vectors, while maintaining the integrity of ITR regions.
GENEWIZ Targeted Yield Plasmid DNA Preparation Service delivers specific quantities of high quality, transfection-grade DNA that you can count on.
GENEWIZ Standard Plasmid DNA Preparation Service is a flexible and fast choice for a range of plasmid templates.
The GENEWIZ Oligos Retained for Sanger service is designed to synthesize, dilute, organize, and store your primers up to a year for use with future Sanger sequencing orders.
Modified Oligos services are designed to equip researchers with customized oligos featuring a wide variety of modifications.